Medicine

C.P. van Schayck, E. Dompeling, C.L.A. van Herwaarden, H. Folgering, A.L.M. Verbeek, H.J.M. van der Hoogen, C. van Weel, "Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study," British Medical Journal, 303:1426-31, 1991. Constant P. van Schayck (Department of General Practice, Nijmegen University, the Netherlands): "We investigated the effects of chronic, continuous use of bronchodilators in asthma and chronic bronchitis. T

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Constant P. van Schayck (Department of General Practice, Nijmegen University, the Netherlands): "We investigated the effects of chronic, continuous use of bronchodilators in asthma and chronic bronchitis. The possibly adverse effects of bronchodilators on the prognosis of asthma and chronic bronchitis is a topical subject nowadays. Long-term studies on this subject are scarce. These studies have begun to appear in the last few years, and they do not seem to justify the fear (or even panic) among patients and doctors of using these bronchodilators.

"It is true that several publications have pointed to the possibly adverse effects of these drugs. However, none of these publications have real-ly proved that bronchodilators are dangerous in the long run. In several epidemiological studies an association was found between the prescription of b2-adrenergic drugs and asthma mortality (J. Crane, et al., Lancet, 1:917-22, 1989; W.O. Spitzer, et al., New England Journal of Medicine, 326:501-6, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies